Retaglutide is a novel GLP-1 receptor agonist currently under research for the control of obesity. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://asiyakuis636315.p2blogs.com/37503938/trelaglutide-exploring-a-new-treatment-for-chronic-diseases